The Oncology Institute, Inc.
TOI
$3.78
$0.020.53%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -66.28M | -65.89M | -64.36M | -64.66M | -70.24M |
| Total Depreciation and Amortization | 7.02M | 6.87M | 6.58M | 6.29M | 6.16M |
| Total Amortization of Deferred Charges | 8.77M | 9.18M | 9.62M | 6.31M | 6.28M |
| Total Other Non-Cash Items | 20.45M | 15.61M | 8.59M | 7.47M | 11.41M |
| Change in Net Operating Assets | 6.41M | 24.04M | 23.92M | 18.06M | 11.77M |
| Cash from Operations | -23.63M | -10.19M | -15.64M | -26.54M | -34.62M |
| Capital Expenditure | -3.90M | -2.89M | -3.51M | -3.79M | -2.90M |
| Sale of Property, Plant, and Equipment | 126.00K | 126.00K | 126.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -156.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 10.00M | 30.00M | 50.00M | 62.64M |
| Cash from Investing | -3.77M | 7.24M | 26.62M | 46.21M | 59.59M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -21.89M | -21.65M | -21.42M | -2.20M | -4.31M |
| Issuance of Common Stock | 28.54M | 17.70M | 15.50M | 75.00K | 188.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.00M | 770.00K | -1.37M | -1.37M | -987.00K |
| Cash from Financing | 7.66M | -3.18M | -7.29M | -3.49M | -5.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.74M | -6.13M | 3.68M | 16.18M | 19.87M |